ROR2 Is a Novel Prognostic Biomarker and a Potential Therapeutic Target in Leiomyosarcoma and Gastrointestinal Stromal Tumour

Journal of Pathology - United States
doi 10.1002/path.3986
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

P1.03-24 TMPRSS4: A Novel Prognostic Biomarker and Therapeutic Target in NSCLC

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

MiR-30a: A Novel Biomarker and Potential Therapeutic Target for Cancer

Journal of Oncology
Oncology
2018English

COL12A1, a Novel Potential Prognostic Factor and Therapeutic Target in Gastric Cancer

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2019English

CD83 Is a New Potential Biomarker and Therapeutic Target for Hodgkin Lymphoma

Haematologica
Hematology
2018English

DDX49 Is a Novel Biomarker and Therapeutic Target for Lung Cancer Metastases

Journal of Cellular and Molecular Medicine
Molecular MedicineCell Biology
2020English

Transgelin in Bladder Cancer: A Potential Biomarker and Therapeutic Target

EBioMedicine
BiochemistryMedicineGeneticsMolecular Biology
2019English

BRG1 Is a Prognostic Marker and Potential Therapeutic Target in Human Breast Cancer

PLoS ONE
Multidisciplinary
2013English

sCLU as Prognostic Biomarker and Therapeutic Target in Osteosarcoma

Bioengineered
Applied MicrobiologyBiotechnologyMedicineBioengineering
2019English

Annexin A8 Is a Prognostic Marker and Potential Therapeutic Target for Pancreatic Cancer

Pancreas
Internal MedicineEndocrinologyHepatologyMetabolismDiabetes
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy